News | Deal Announcement
Baker McKenzie Advises Baxter in USD 3.8 Billion Divestiture of Vantive Kidney Care Segment to Carlyle
The deal represents a key milestone in Baxter’s ongoing business transformation, enabling heightened strategic clarity, operational efficiency and innovation.